| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -38.0% | -3.4% |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | 226.8 |
| PEG | n/a | n/a |
| Pr/Revenue | 9.6 | 7.9 |
| Pr/Book | 2.2 |
| Latest | F'cast | |
|---|---|---|
| Revenue | -7.6% | 21.4% |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-09 | 31.20 | (19.60) | (5.20)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-10 | 40.10 | (13.80) | (3.20)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-11 | 42.90 | (13.30) | (2.70)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-12 | 33.00 | (13.20) | (1.30)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-13 | 30.50 | (10.40) | (1.80)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-14 | 37.03 | (1.26) | 0.38p | 226.8 | n/a | n/a | n/a | 0.0% |
| 31-Mar-15 | 51.83 | 12.76 | 3.50p | 24.8 | 0.0 | +813% | n/a | 0.0% |
Copyright © 2013 FactSet Research Systems Inc. All rights reserved.
| Holding(s) in Company | 21-May-2013 | 13:44 | RNS |
| Board Change | 21-May-2013 | 07:00 | RNS |
| Final Results | 21-May-2013 | 07:00 | RNS |
| Wednesday broker round-up UPDATE | 22-May-2013 | ShareCast |
| Monday broker round-up UPDATE | 17-Dec-2012 | ShareCast |
| Friday broker round-up UPDATE | 30-Nov-2012 | ShareCast |
| One to watch: Vectura | 13-Jul-2011 | The Scotsman |
| The potential for inhalable drugs to change medi... | 19-Feb-2007 | Times |
| Asthma venture gives Vectura boost | 22-Dec-2006 | The Independent |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 87.00p |
| Change Today | -2.00p |
| % Change | -2.25 % |
| 52 Week High | 96.75 |
| 52 Week Low | 64.00 |
| Volume | 266,563 |
| Shares Issued | 334.81m |
| Market Cap | £291.29m |
| Beta | 0.11 |
| RiskGrade | 124 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 7 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 7 |

| No dividends found |
| Time | Volume / Share Price |
| 16:35 | 4,236 @ 87.00p |
| 16:35 | 19,031 @ 87.00p |
| 16:26 | 232 @ 87.50p |
| 16:26 | 232 @ 87.50p |
| 16:25 | 464 @ 87.25p |
| CEO | Chris Blackwell |
| COO | Trevor Phillips |
You are here: research